• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Microbiology - Articles and news items

Steven Brimble appointed as new Quality Manager for Cherwell

Steven Brimble appointed as new Quality Manager for Cherwell

Supplier news / 15 December 2016 / Cherwell Laboratories

Company continues its emphasis on delivering quality environmental monitoring and cleanroom microbiology solutions…

Digital issues 6 RMMs supplement

RMMs In-Depth Focus

Issue 6 2016, Supplements, Z Homepage promo / 13 December 2016 / European Pharmaceutical Review

In this supplement: the role of statistical analysis in validating rapid microbiological methods; considerations when using RMMs for use in pharmaceutical microbiology; & RMMs roundtable…

Wickham Labs logo

Wickham Labs to Exhibit at Pharmig 2016

Supplier news / 3 November 2016 / Wickham Laboratories Limited

Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th…

Demand for Cherwell’s SAS Air Sampler Calibration service continues to rise year-on-year

Supplier news / 30 September 2016 / Cherwell Laboratories

Overall demand up by 15% with on-site calibrations showing most significant rise…

Wickham Labs logo

Joint article on hydrogen peroxide efficacy published in Letters in Applied Microbiology

Supplier news / 23 September 2016 / Wickham Laboratories Limited

Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection by hydrogen peroxide…

Current activities of the USP general chapters

Issue 4 2016 / 24 August 2016 / Radhakrishna Tirumalai, PhD, United States Pharmacopeial Convention

From a microbiological perspective, pharmaceutical products fall into two categories – nonsterile and sterile. For both categories manufacturers must eliminate, or minimise, potential health risks to patients related to microorganisms and the toxins they produce, whilst maintaining product quality. Many contributing factors may affect the quality of a medicine or its ingredients, but microbial bioburden […]

Microbiological environmental monitoring features in two national conferences supported by Cherwell Laboratories

Microbiological environmental monitoring features in two national conferences supported by Cherwell Laboratories

Supplier news / 9 August 2016 / Cherwell Laboratories

Cherwell to offer expert insight in environmental monitoring and process validation to both NHS and industrial pharmaceutical manufacturers…

Wickham Labs logo

Joint article on hydrogen peroxide efficacy published in letters in applied microbiology

Supplier news / 8 August 2016 / Wickham Laboratories

Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection by hydrogen peroxide…

Method suitability in microbiology: understanding complex cGMP guidelines

Method suitability in microbiology: understanding complex cGMP guidelines

Microbiology / RMMs, Whitepapers, Z Homepage promo / 15 July 2016 / Wickham Labs

Particularly in the pharmaceutical industry, microbiological method development and, specifically, method suitability is often overlooked or left until the end of a project. However, it is important to give both method suitability and development due consideration as it can be a complicated process involving wide specifications, vague parameters and the inherent variation that comes from working with living organisms…

Microbiology In-Depth Focus 2016

Microbiology: In-Depth Focus 2016

Issue 3 2016, Microbiology / RMMs, Supplements, Z Homepage promo / 30 June 2016 / European Pharmaceutical Review

Featuring: Risk-based microbiological testing; Improving microbiological assurance for bioburden testing; Microbiology Roundtable.

Eppendorf expands single-use vessel portfolio for microbial fermentation

Supplier news / 31 May 2016 / Eppendorf

Eppendorf’s BioBLU 3f Single-Use Vessels specifically address the demands of high cell density fermentation of bacteria, yeasts and fungi…

A novel approach in assessing the antimicrobial efficacy of eye drop products

A novel approach in assessing the antimicrobial efficacy of eye drop products

Issue 2 2016, Microbiology / RMMs / 4 May 2016 / Mostafa Eissa, Hikma Pharmaceuticals

The microbial contamination of medicinal products constitutes a continuous threat to the health of consumers, which may negatively impact pharmaceutical companies’ reputability. However, multidose sterile pharmaceutical products are prone to contamination either from the normal flora of the human body or from the surrounding environment, following their misuse by patients. With the absence of strict medical supervision from medical professionals, patients can infect themselves with such a contaminated product. The study described in this article provides a new prospective view on the preservative efficacy test (PET) to assess the potency of antimicrobial agent(s) in two formulae of eye drops as well as quantitatively determining the risk of recontamination by the consumer…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +